Role of the Laboratory in Ensuring Global Access to ARV Treatment for HIV-Infected Children
Author Information
Author(s): W. Stevens, G. Sherman, R. Downing, L.M. Parsons, C.-Y. Ou, S. Crowley, G.M. Gershy-Damet, K. Fransen, M. Butlerys, L. Lu, J. Homsy, T. Finkbeiner, J.N. Nkengasong
Primary Institution: University of the Witwatersrand and National Health Laboratory Service
Hypothesis
How can laboratory assays improve early infant diagnosis of HIV infection?
Conclusion
The consensus statement emphasizes the importance of using reliable laboratory assays for early infant diagnosis of HIV to ensure timely access to treatment.
Supporting Evidence
- Data from Zambia showed that 30-50% of infected infants died by two years of age.
- Studies from South Africa found that 40% of HIV-infected infants died by 12 months of age.
- Consensus was reached on the usefulness of dried blood spot specimens for HIV testing in children.
Takeaway
This study shows that using specific tests can help find out if babies have HIV early, which is really important for getting them the right medicine.
Methodology
A two-day meeting was held to review laboratory performance of virologic methods for diagnosing HIV-1 in infants, with data shared from 9 African countries.
Limitations
The study acknowledges that some assays may not detect future variants of HIV and that there are challenges related to staff training and resource availability.
Participant Demographics
Participants included healthcare professionals from 17 countries, focusing on high-burden HIV regions in Africa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website